stockrowACADIA Pharmaceuticals Inc. (ACAD) vs Xenon Pharmaceuticals Inc. (XENE)
- ACADIA Pharmaceuticals Inc. ACAD 21.23 −0.05%
- Xenon Pharmaceuticals Inc. XENE 39.00 +3.50%
ACADIA Pharmaceuticals Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. ACADIA Pharmaceuticals Inc. and Xenon Pharmaceuticals Inc. are of similar size ($3.7B and $3.7B). Xenon Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; ACADIA Pharmaceuticals Inc. trades at 10.0×. ACADIA Pharmaceuticals Inc. grew revenue faster over the last twelve months: 14.8% against −8.15%. ACADIA Pharmaceuticals Inc. has the higher net margin (30.1% vs 0.00%) and the higher return on invested capital (18.6% vs −88.5%). Across the 17 metrics below, ACADIA Pharmaceuticals Inc. leads on 15 and Xenon Pharmaceuticals Inc. on 2.
Valuation
Profitability
| Metric | ACAD | XENE | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.48% | 28.40% | 68.51% |
| Operating margin | 10.17% | 0.00% | 0.00% |
| Net margin | 30.13% | 0.00% | 0.00% |
| Free cash flow margin | 6.82% | 0.00% | 0.00% |
| Return on equity | 31.43% | (43.62%) | (51.96%) |
| Return on assets | 23.18% | (41.54%) | (46.06%) |
| Return on invested capital | 18.60% | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack